showed a trendp = 0.10
OVA challenge in control-treated mice induced typical AHR, while mice that had received a Pam3Cys treatment at the first two OVA inhalation challenges showed a trend towards a reduced AHR (p = 0.10) ( Figure 2a for the 20 μg/mouse dose of Pam3Cys).